Your browser doesn't support javascript.
loading
Change in quality of life of stage IA non-small cell lung cancer after surgery or radiation therapy.
Zhang, Jiafang; Yip, Rowena; Taioli, Emanuela; Flores, Raja M; Henschke, Claudia I; Yankelevitz, David F; Schwartz, Rebecca M.
Afiliação
  • Zhang J; Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Yip R; Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Taioli E; Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Flores RM; Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Henschke CI; Tisch Center Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Yankelevitz DF; Center for Thoracic Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Schwartz RM; Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
J Thorac Dis ; 16(1): 147-160, 2024 Jan 30.
Article em En | MEDLINE | ID: mdl-38410593
ABSTRACT

Background:

Few studies have examined the differential impact of stereotactic body radiotherapy (SBRT) and surgery for early-stage non-small cell lung cancer (NSCLC) on quality of life (QoL) during the first post-treatment year.

Methods:

A prospective cohort of stage IA NSCLC patients undergoing surgery or SBRT at Mount Sinai Health System had QoL measured before treatment, and 2, 6, and 12 months post-treatment using 12-item Short Form Health Survey version 2 (SF-12v2) [physical component summary (PCS) and mental component summary (MCS)], Functional Assessment of Cancer Therapy-Lung Cancer Subscale (FACT-LCS), and the Patient Health Questionnaire-4 (PHQ-4) measuring depression and anxiety. Locally weighted scatterplot smoothing (LOWESS) was fitted to identify the best interval knot for the change in the QoL trends post-treatment, adjusted piecewise linear mixed effects model was developed to estimate differences in baseline, 2- and 12-month scores, and rates of change.

Results:

In total, 503 (88.6%) patients received surgery and 65 (11.4%) SBRT. LOWESS plots suggested QoL changed at 2 months post-surgery. Worsening in PCS was observed for both surgery and SBRT within 2 months after treatment but was only significant for surgical patients (-2.11, P<0.001). Two months later, improvements were observed for surgical but not SBRT patients (0.63 vs. -0.30, P<0.001). Surgical patients had significantly better PCS (P<0.001) and FACT-LCS (P<0.001) scores 1-year post-treatment compared to baseline, but not SBRT patients. Both surgical and SBRT patients reported significantly less anxiety 1-year post-treatment compared to baseline (P<0.001 and P=0.03). Decrease in depression from baseline to 1-year post-treatment was only significant for surgical patients (P<0.001).

Conclusions:

Post-treatment, surgical patients exhibited improvements in physical health and reductions in lung cancer symptoms following initial deterioration within the first two months; in contrast, SBRT patients showed persistent decline in these areas throughout the year. Nonetheless, improved mental health was noted across both patient categories post-treatment. Targeted interventions and continuous monitoring are recommended during the initial 2 months post-surgery and throughout the year post-SBRT to alleviate physical and mental distress in patients.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article